Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
pasquale.pignatelli@uniroma1.it
Pasquale Pignatelli
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
pasquale.pignatelli@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Use of direct oral anticoagulants in patients with antiphospholipid syndrome. a systematic review and comparison of the international guidelines
FRONTIERS IN CARDIOVASCULAR MEDICINE
2021
Circulating lipopolysaccharides and impaired antioxidant status in patients with atrial fibrillation. data from the athero-af study
FRONTIERS IN CARDIOVASCULAR MEDICINE
2021
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes. insights from the START-ANTIPLATELET registry
INTERNATIONAL JOURNAL OF CARDIOLOGY
2021
Thrombosis in pre- and post-vaccination phase of COVID-19
EUROPEAN HEART JOURNAL SUPPLEMENTS
2021
COVID-19 and thrombosis: Clinical features, mechanism of disease, and therapeutic implications
KARDIOLOGIA POLSKA
2021
Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets
PLATELETS
2021
Low-grade endotoxemia and thrombosis in COVID-19
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
2021
Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. the nationwide PLECTRUM study
BRITISH JOURNAL OF HAEMATOLOGY
2020
Upper extremity deep vein thrombosis treated with direct oral anticoagulants. a multi-center real world experience
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
2020
Seronegative antiphospholipid syndrome: Refining the value of “non-criteria” antibodies for diagnosis and clinical management
HAEMATOLOGICA
2020
Optimal medical therapy on top of dual-antiplatelet therapy. 1-year clinical outcome in patients with acute coronary syndrome: the start antiplatelet registry
ANGIOLOGY
2020
A novel role of MMP2 in regulating platelet NOX2 activation
FREE RADICAL BIOLOGY & MEDICINE
2020
PCSK9 regulates Nox2-mediated platelet activation via CD36 receptor in patients with atrial fibrillation
ANTIOXIDANTS
2020
Integrated care management of patients with atrial fibrillation-far from optimal
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ
2020
Serum albumin and risk of cardiovascular events in primary and secondary prevention: a systematic review of observational studies and Bayesian meta-regression analysis
INTERNAL AND EMERGENCY MEDICINE
2020
Nutrition, thrombosis, and cardiovascular disease
CIRCULATION RESEARCH
2020
Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation. a multicentre cohort study
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
2020
Hypercoagulation and antithrombotic treatment in coronavirus 2019. a new challenge
THROMBOSIS AND HAEMOSTASIS
2020
IS ALBUMIN PREDICTOR OF MORTALITY IN COVID-19 ?
ANTIOXIDANTS & REDOX SIGNALING
2020
Is albumin predictor of mortality in COVID-19?
ANTIOXIDANTS & REDOX SIGNALING
2020
« prima
< precedente
…
2
3
4
5
6
7
8
9
10
11
12
13
seguente ›
ultima »
ERC
LS1_2
LS1_5
LS2_16
LS3
LS4
LS4_3
LS4_7
LS4_10
LS8_4
Keywords
Modulation of Oxidative Stress
Platelets
Atherothrombosis
Thrombosis
Progetti di Ricerca
The role of gut permeability in patients with cardiovascular disease
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9), PLATELET ACTIVATION AND RISK OF CARDIOVASCULAR EVENTS IN ATRIAL FIBRILLATION
PCSK9 as a predictor of cardiovascular events in atrial fibrillation: role of platelet activation.
PCSK9 e attivazione piastrinica: implicazioni nei pazienti con fibrillazione atriale
Gruppi di ricerca
Cardiologia geriatrica
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma